or Try an Advanced Search...

    Technical Analysis for ONCO - Onconetix, Inc.

    Grade Last Price % Change Price Change
    F 1.08 -5.26% -0.06
    ONCO closed down 5.26 percent on Wednesday, November 20, 2024, on 10 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ONCO trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish -5.26%
    New 52 Week Low Weakness -5.26%
    Wide Bands Range Expansion -5.26%
    Down 3 Days in a Row Weakness -5.26%
    Older End-of-Day Signals for ONCO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 16 hours ago
    Up 5% about 16 hours ago
    Up 3% about 16 hours ago
    Up 2% about 16 hours ago
    Up 1% about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ONCO Chart by TradingView
    Basic chart:

    Profile

    Onconetix, Inc. (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology FDA Disorders Prostate Cancer Urology Benign Prostatic Hyperplasia Bph Men's Health Prostate Treatment Of Benign Prostatic Hyperplasia

    Is ONCO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 3 Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    Oct 3 Onconetix announces $2M private placement, and establishes $25M equity line of credit
    Oct 3 Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit
    Sep 27 Crude Oil Rises; Onconetix Shares Spike Higher
    Sep 27 Onconetix rallies after Altos Venture reports 32.5% stake
    Sep 27 Dow Surges Over 100 Points; Costco Earnings Top Views
    Sep 20 Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
    Jul 22 Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
    Jul 19 Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Jul 18 US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
    See more ONCO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.4
    52 Week Low 1.01
    Average Volume 830,297
    200-Day Moving Average 5.61
    50-Day Moving Average 3.89
    20-Day Moving Average 2.40
    10-Day Moving Average 1.67
    Average True Range 0.35
    RSI (14) 18.70
    ADX 40.37
    +DI 13.77
    -DI 45.90
    Chandelier Exit (Long, 3 ATRs) 4.44
    Chandelier Exit (Short, 3 ATRs) 2.07
    Upper Bollinger Bands 4.16
    Lower Bollinger Band 0.65
    Percent B (%b) 0.12
    BandWidth 145.97
    MACD Line -0.89
    MACD Signal Line -0.79
    MACD Histogram -0.0945
    Fundamentals Value
    Market Cap 24.11 Million
    Num Shares 22.3 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 0.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.35
    Resistance 3 (R3) 1.38 1.32 1.31
    Resistance 2 (R2) 1.32 1.25 1.31 1.29
    Resistance 1 (R1) 1.20 1.21 1.17 1.17 1.27
    Pivot Point 1.14 1.14 1.13 1.13 1.14
    Support 1 (S1) 1.02 1.07 0.99 0.99 0.89
    Support 2 (S2) 0.96 1.03 0.95 0.87
    Support 3 (S3) 0.84 0.96 0.86
    Support 4 (S4) 0.81